Elwakeel und Hazaa (2015) [29] | Deore et al. (2014) [30] | Elkhouli (2011) [13] | El-Sharkawy et al. (2010) [15] | Martinez et al. (2014) [31] | Keskiner et al. (2017) [32] | |
---|---|---|---|---|---|---|
Clinical trial | Yes | Yes | Yes | Yes | Yes | Yes |
Randomised, controlled | Yes | Yes | Yes | Yes | Yes | Yes |
Chronic periodontitis (CP) | moderate-severe CP + diabetes type2 | moderate-severe CP | moderate-severe periodontitis +at least 1 furcation degree 2 | severe CP | light, moderate, severe CP | Yes |
Gingivitis | No | No | No | No | No | No |
Smoker | No | No | Yes (< 10/day) | No | Yes | No |
Omega3-fatty acids dosage | 1000 mg, 3x/ day for 6 months | 300 mg(180 mg EPA, 120 mg DHA), 1x/day for 12 weeks | 1000 mg (300 mg DHA+ 150 mg EPA) 3x/day for 6 months | 900 mg EPA, 900 mg DHA, wheat germ oil | 300 mg (each 180 mg EPA+ 120 mg DHA) 3x/day for 12 months | 6.25 mg EPA, 19.19 mg DHA 2x/day for 6 months |
Aspirin | 75 mg, 1x/day for 6 months only test group | No | 75 mg 1x /day für 6 months | 81 mg 1x /day | No | No |
Placebo | Coconut oil for omega-3, lactose for aspirin | 300 mg paraffin / day | Yes | Yes | Yes | Yes |
Number of patients | 40 (20/20) | 60 (30/30) | 40 (20/20) | 80 (40/40) | 15 (test 7/control 8) | 30 (15/15) |
Number of examiners | 1 | 1 | 1 | at least 2 calibrated | > 1 exact specification is missing,calibrated | 1 |
Study period | 6 months | 3 months | 6 months | 6 months | 12 months | 6 months |
Oral hygiene instructions | Yes | Yes | Yes | Yes | No | Yes |
Subgingival instrumentation | Yes | Yes | Yes | Yes | Yes | Yes |
Clinical periodontal parameter | OHIS | |||||
GI | Yes | Yes | Yes | Yes | No | Yes |
PI | Yes | Yes | Yes | Yes | Yes | Yes |
BOP | No | No (only at baseline) | Gingival bleeding index | Yes | Yes | Yes |
PD | Yes | Yes | Yes | Yes | Yes | Yes |
CAL | Yes | Yes | Yes | Yes | Yes | Yes |
Recording of the parameters | 0, 3, 6 months | 0, 1.5, 3 months | 0, 3, 6 months | 0, 3, 6 months | 0,4,12 months | 0,1,3,6 months |